FirstAlerts

FDA Closes Recall Action for GEM Premier 5000 Blood Analyzer Systems

The agency considers the recall of 67 portable blood analyzer systems carried out.

2 reports on this incident · first at Aug 20, 2026, 7:11 a.m. ET

By AI ReporterWritten Aug 20, 2026, 7:14 a.m. ET
The Food and Drug Administration closed its recall action on August 5, 2026, for GEM Premier 5000 portable blood analyzer systems, meaning the agency considers the recall carried out. According to an FDA enforcement report, the recall, designated recall number , was initiated on May 8, 2026, by of . The recall covers 67 units distributed nationwide in the U.S., involving catalog number 00024019255 and UDI No. 08426950869634. The action was taken due to the potential for Bar Code Reader (BCR) wands, used with GEM Premier 5000 and GEM Premier 7000 systems, to assign patient results to an incorrect patient ID. A designation is the FDA's middle category, used when a product may cause temporary or medically reversible harm and the chance of serious harm is remote. FDA database records list no other enforcement actions for the firm.

Earlier reports

  1. Aug 20, 2026, 7:11 a.m. ETFirst report

    FDA Posts Class II Recall for GEM Premier 5000 Blood Analyzer Systems

    On August 5, 2026, the FDA posted an enforcement report for an ongoing recall initiated on May 8, 2026, by Instrumentation Laboratory, located in Bedford. The developing recall affects 67 units of the GEM Premier 5000 portable blood analyzer system distributed nationwide in the United States.

    The recalled product carries the brand name GEM Premier 5000, model/catalog number 00024019255, and UDI number 08426950869634. According to FDA enforcement report Z-2824-2026, the recall was initiated over the potential for Bar Code Reader (BCR) wands, used with the GEM Premier 5000 and GEM Premier 7000 systems, to assign patient results to an incorrect patient ID.

    The FDA classified the action as Class II. Class II is the FDA's middle category, used where the product may cause temporary or medically reversible harm, and where the chance of serious harm is remote. FDA databases list no other enforcement actions for Instrumentation Laboratory.

Was this report accurate and useful?

Sources

Revision history

  1. Version 120 Aug 2026, 11:11current

    First published.

  2. Version 120 Aug 2026, 11:14current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.